Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Impact of Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin in Patients Being Initiated on Oral Anticoagulation

NCT00927862 is registered in ClinicalTrials.gov with Intermountain Health Care, Inc. as lead sponsor.

NCT NCT00927862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Impact of Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin in Patients Being Initiated on Oral Anticoagulation
Lead sponsor
Intermountain Health Care, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2008
Completion date
June 30, 2011
Enrollment
2,415 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism